Skip to content
Recall Observatory FDA recall evidence

Drug product

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

D-1124-2017

August 15, 2017

Class II

Product summary

Firm
Amphastar Pharmaceuticals, Inc.
Event
Event 77988
Status
Terminated
Classification
Class II
Quantity
637,810 vials
Official record key
drug-enforcement:D-1124-2017

Official wording

Reason: Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.

Code information: Lot # XI002A6, XI003A6, Exp 12/17; XI004G6, XI005G6, Exp 6/18; XI007H6, Exp 7/18; XI00816, XI00916, XI01016, XI01116, Exp 8/18; XI012J6, XI013J6, Exp 9/18; XI015K6, Exp 10/18; XI016L6, Exp 11/18; XL018A7, XI019A7, Exp 12/18; XI020B7, XI021B7, Exp 1/19; XI022C7, XI023C7, Exp 2/19; XI025D7, Exp 3/19.

Distribution pattern: Distributed throughout the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate matter